BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)

  November 13, 2024

   · 

  11 min read
• Press Releases

  Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

  November 13, 2024

   · 

  18 min read
• Press Releases

  Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH

  November 13, 2024

   · 

  17 min read
• Press Releases

  Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow

  November 13, 2024

   · 

  13 min read
• Press Releases

  Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive Strategic Collaboration for ATSN-101 in the U.S. and Japan

  November 13, 2024

   · 

  5 min read
• Press Releases

  Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology

  November 13, 2024

   · 

  8 min read
• Press Releases

  Oculis to Present at the Stifel 2024 Healthcare Conference

  November 13, 2024

   · 

  1 min read
• Press Releases

  Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

  November 13, 2024

   · 

  8 min read
• Press Releases

  AC Immune to Present at the Jefferies 2024 London Healthcare Conference

  November 13, 2024

   · 

  3 min read
• Press Releases

  Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress

  November 13, 2024

   · 

  12 min read